Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2022 Apr 28;28(6):e205–e210. doi: 10.1097/SPV.0000000000001185

Figure 3: Urinary secretory IgA levels in aged mice with and without methenamine hippurate treatment.

Figure 3:

NS Non-significant, p >0.05

* p ≤0.05

** p ≤0.01

*** p ≤0.001

**** p ≤0.0001

Filled dots: aged mice without MH treatment (NP)

Empty squares: aged mice treated with MH (MH)

There was a significant difference between urinary IgA levels between aged mice treated with MH compared to controls at most time points after infection.